AAAAAA

   
Results: 1-25 | 26-39
Results: 1-25/39

Authors: WETZLER M BERNSTEIN SH BAUMANN H FRIES KM STEWART C BLUMENSON L BAER MR HERZIG GP BLOOMFIELD CD SLACK JL
Citation: M. Wetzler et al., EXPRESSION AND FUNCTION OF THE MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR-RECEPTOR IN ACUTE MYELOID-LEUKEMIA BLASTS, Leukemia & lymphoma, 30(5-6), 1998, pp. 415

Authors: XIA Z BAER MR BLOCK AMW BAUMANN H WETZLER M
Citation: Z. Xia et al., EXPRESSION OF SIGNAL TRANSDUCERS AND ACTIVATORS OF TRANSCRIPTION PROTEINS IN ACUTE MYELOID-LEUKEMIA BLASTS, Cancer research, 58(14), 1998, pp. 3173-3180

Authors: SHAH M JENIS EH MOOKERJEE BK SCHRIBER JR BAER MR HERZIG GP WETZLER M
Citation: M. Shah et al., INTERFERON-ALPHA-ASSOCIATED FOCAL SEGMENTAL GLOMERULOSCLEROSIS WITH MASSIVE PROTEINURIA IN PATIENTS WITH CHRONIC MYELOID-LEUKEMIA FOLLOWINGHIGH-DOSE CHEMOTHERAPY, Cancer, 83(9), 1998, pp. 1938-1946

Authors: GISSLINGER H KURZROCK R WETZLER M TUCKER S KANTARJIAN H ROBERTSON B TALPAZ M
Citation: H. Gisslinger et al., APOPTOSIS IN CHRONIC MYELOGENOUS LEUKEMIA - STUDIES OF STAGE-SPECIFICDIFFERENCES, Leukemia & lymphoma, 25(1-2), 1997, pp. 121

Authors: WETZLER M BAER MR BERNSTEIN SH BLUMENSON L STEWART C BARCOS M MROZEK K BLOCK AMW HERZIG GP BLOOMFIELD CD
Citation: M. Wetzler et al., EXPRESSION OF C-MPL MESSENGER-RNA, THE RECEPTOR FOR THROMBOPOIETIN, IN ACUTE MYELOID-LEUKEMIA BLASTS IDENTIFIES A GROUP OF PATIENTS WITH POOR RESPONSE TO INTENSIVE CHEMOTHERAPY, Journal of clinical oncology, 15(6), 1997, pp. 2262-2268

Authors: LEVY AS BROMBERG J WETZLER M SPOO J LEWARS M WHITELAW GP
Citation: As. Levy et al., THE ORTHOPEDIC AND SOCIAL OUTCOME OF OPEN TIBIA FRACTURES IN CHILDREN, Orthopedics, 20(7), 1997, pp. 593-598

Authors: WETZLER M KURZROCK R ESTROV Z BARONE S ESTEY E TALPAZ M
Citation: M. Wetzler et al., SUPPRESSED FORMATION OF BONE-MARROW ADHERENT LAYERS DERIVED FROM ACUTE MYELOID-LEUKEMIA PATIENTS AFTER IN-VITRO EXPOSURE TO INTERLEUKIN-4, Leukemia research, 21(6), 1997, pp. 519-527

Authors: XIA Z BAER MR BLOCK AW BAUMANN H WETZLER M
Citation: Z. Xia et al., CONSTITUTIVE ACTIVATION OF SIGNAL TRANSDUCERS AND ACTIVATORS OF TRANSCRIPTION PROTEINS (STATS) AND PROTEIN-TYROSINE KINASE (PTK) IN ACUTE MYELOID-LEUKEMIA (AML) BLASTS - NOVEL PATHWAYS FOR LEUKEMOGENESIS, Blood, 90(10), 1997, pp. 3617-3617

Authors: ALAM A BAER MR BERNSTEIN S BERNSTEIN Z CHRISTIANSEN N CZUCZMAN M SCHRIBER J SLACK J TEZCAN H WETZLER M COOPER M MILK B FORD L HERZIG G MCCARTHY P
Citation: A. Alam et al., PHASE-II CLINICAL-TRIAL OF OKT3 FOR ACUTE GRAFT-VERSUS-HOST DISEASE (GVHD) PROPHYLAXIS IN ALLOGENEIC BONE-MARROW TRANSPLANTATION (ALLOBMT), Blood, 90(10), 1997, pp. 449-449

Authors: ALIDINA A BAER R BERNSTEIN S BERNSTEIN Z CHRISTIANSEN N CZUCZMAN M SCHRIBER J SLACK J SPANGENTHAL T TEZCAN H WETZLER M MILK B SWINNICH D FORD L HERZIG G MCCARTHY P
Citation: A. Alidina et al., THIOTEPA-ASSOCIATED CARDIOMYOPATHY DURING HEMATOPOIETIC STEM-CELL TRANSPLANTATION, Blood, 90(10), 1997, pp. 984-984

Authors: SCHRIBER JR BAER MR CHRISTIANSEN NP MCCARTHY PL SLACK JL TEZCAN H WETZLER M HERZIG GP
Citation: Jr. Schriber et al., MURINE MONOCLONAL-ANTIBODY DIRECTED AGAINST CD3 (OKT3) IS AN EFFECTIVE TREATMENT FOR MODERATE (GRADE-II) BUT NOT FOR SEVERE (GRADE-III OR GRADE-IV) STEROID-RESISTANT GRAFT-VERSUS-HOST DISEASE (GVHD), Blood, 88(10), 1996, pp. 3786-3786

Authors: SCHRIBER JR MOOKERJEE BK BAER MR CHRISTIANSEN NP MCCARTHY PL SLACK JL TEZCAN H WETZLER M HERZIG GP
Citation: Jr. Schriber et al., EFFICACY OF HEMODIALYSIS (HD) AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT), Blood, 88(10), 1996, pp. 460-460

Authors: BAUMANN H KUROPATWINSKI KK WANG Y KIM H KORDULA T RIPPERGER J FEY GH VANETTEN RA WETZLER M
Citation: H. Baumann et al., BCR ABL KINASES MIMIC HEMATOPOIETIN RECEPTORS BY ACTIVATING COMMON SETS OF SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION (STAT) PROTEINSAND INDUCING GENE-EXPRESSION THROUGH CYTOKINE-RESPONSIVE ELEMENTS/, Blood, 88(10), 1996, pp. 804-804

Authors: SCHRIBER JR MILK BJ BAER MR CHRISTIANSEN NP MCCARTHY PL SLACK JL TEZCAN H WETZLER M HERZIG GP
Citation: Jr. Schriber et al., A RANDOMIZED PHASE-II TRIAL COMPARING HEPARIN (HEP)+ -PROSTAGLANDIN-E1 (PG) TO PREVENT HEPATOTOXICTY (HT) FOLLOWING BONE-MARROW TRANSPLANTATION (BMT) - PRELIMINARY-RESULTS/, Blood, 88(10), 1996, pp. 1642-1642

Authors: WETZLER M BAER MR BERNSTEIN SH BLUMENSON L STEWART C BARCOS M MROZEK K BLOCK AMW HERZIG GP BLOOMFIELD CD
Citation: M. Wetzler et al., EXPRESSION OF MESSENGER-RNA ENCODING C-MPL, THE RECEPTOR FOR THROMBOPOIETIN, IN ACUTE MYELOID-LEUKEMIA (AML) BLASTS IDENTIFIES A GROUP OF PATIENTS (PTS) WITH POOR OUTCOME TO INTENSIVE CHEMOTHERAPY, Blood, 88(10), 1996, pp. 2526-2526

Authors: KURZROCK R WETZLER M ESTROV Z TALPAZ M
Citation: R. Kurzrock et al., INTERLEUKIN-1 AND ITS INHIBITORS - A BIOLOGIC AND THERAPEUTIC MODEL FOR THE ROLE OF GROWTH-REGULATORY FACTORS IN LEUKEMIAS, Cytokines and molecular therapy, 1(3), 1995, pp. 177-184

Authors: SEYMOUR JF TALPAZ M CABANILLAS F WETZLER M KURZROCK R
Citation: Jf. Seymour et al., SERUM INTERLEUKIN-4 LEVELS CORRELATE WITH PROGNOSIS IN DIFFUSE LARGE-CELL LYMPHOMA, Journal of clinical oncology, 13(3), 1995, pp. 575-582

Authors: WETZLER M KURZROCK R ESTROV Z ESTEY E TALPAZ M
Citation: M. Wetzler et al., CYTOKINE EXPRESSION IN ADHERENT LAYERS FROM PATIENTS WITH MYELODYSPLASTIC SYNDROME AND ACUTE MYELOGENOUS LEUKEMIA, Leukemia research, 19(1), 1995, pp. 23-34

Authors: WETZLER M TALPAZ M YEE G STASS SA VANETTEN RA ANDREEFF M GOODACRE AM KLEINE HD MAHADEVIA RK KURZROCK R
Citation: M. Wetzler et al., CELL CYCLE-RELATED SHIFTS IN SUBCELLULAR-LOCALIZATION OF BCR - ASSOCIATION WITH MITOTIC CHROMOSOMES AND WITH HETEROCHROMATIN, Proceedings of the National Academy of Sciences of the United Statesof America, 92(8), 1995, pp. 3488-3492

Authors: WETZLER M KURZROCK R GOODACRE AM MCLAUGHLIN P KU S TALPAZ M
Citation: M. Wetzler et al., TRANSFORMATION OF CHRONIC LYMPHOCYTIC-LEUKEMIA TO LYMPHOMA OF TRUE HISTIOCYTIC TYPE, Cancer, 76(4), 1995, pp. 609-617

Authors: BERNSTEIN SH BAER MR LAWRENCE D HERZIG GP BLOOMFIELD CD WETZLER M
Citation: Sh. Bernstein et al., SERIAL DETERMINATION OF THROMBOPOIETIN (TPO), IL-3, IL-6, IL-11 AND LEUKEMIA INHIBITORY FACTOR (LIF) LEVELS IN PATIENTS UNDERGOING CHEMOTHERAPY FOR ACUTE MYELOID-LEUKEMIA (AML), Blood, 86(10), 1995, pp. 170-170

Authors: SCHRIBER J CHRISTIANSEN N BAER MR SLACK J WETZLER M HERZIG G
Citation: J. Schriber et al., TISSUE-PLASMINOGEN ACTIVATOR (TPA) AS THERAPY FOR HEPATOTOXICITY FOLLOWING BONE-MARROW TRANSPLANTATION, Blood, 86(10), 1995, pp. 869-869

Authors: SCHRIBER J CHRISTIANSEN N BAER MR STACK J WETZLER M HERZIG G
Citation: J. Schriber et al., HIGH-DOSE THIOTEPA AND CAREOPLANTINUM PREPARATIVE REGIMEN FOR AUTOLOGOUS BONE-MARROW TRANSPLANTATION (BMT) - A PHASE I-II STUDY, Blood, 86(10), 1995, pp. 3845-3845

Authors: WETZLER M KANTARJIAN H KURZROCK R TALPAZ M
Citation: M. Wetzler et al., INTERFERON-ALPHA THERAPY FOR CHRONIC MYELOGENOUS LEUKEMIA, The American journal of medicine, 99(4), 1995, pp. 402-411

Authors: FERRAJOLI A TALPAZ M ORDONEZ NG STANLEY ER HIRSCHGINSBERG C ZIPF TF WETZLER M KURZROCK R ESTROV Z
Citation: A. Ferrajoli et al., INTERLEUKIN-4 ALTERS HUMAN BONE-MARROW STROMA AND MODULATES ITS INTERACTION WITH HEMATOPOIETIC PROGENITORS, Stem cells, 12(6), 1994, pp. 638-649
Risultati: 1-25 | 26-39